BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3938942)

  • 1. [Eicosanoids, myocardial ischemia and sudden death].
    Jouve R; Larrue J
    Arch Mal Coeur Vaiss; 1985 Dec; 78 Spec No():49-55. PubMed ID: 3938942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac death prevention in post-myocardial infarction patients: a review.
    Boissel JP; Leizorovicz A; Faucomprez C
    Acta Cardiol Suppl; 1980; (25):147-79. PubMed ID: 6103625
    [No Abstract]   [Full Text] [Related]  

  • 3. A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease.
    Genton E
    Circulation; 1980 Dec; 62(6 Pt 2):V111-21. PubMed ID: 6108166
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacotherapy of sudden cardiac death due to acute myocardial ischaemia. Experimental and clinical experience.
    Szekeres L
    Cor Vasa; 1986; 28(2):123-37. PubMed ID: 3524989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
    Turpie AG
    Prog Clin Biol Res; 1982; 89():31-62. PubMed ID: 7051035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term antithrombotic treatment in coronary disease].
    Hodara M; Samama M
    J Mal Vasc; 1983; 8(1):28-32. PubMed ID: 6405004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of sulfinpyrazone on early ventricular fibrillation and 2d-phase arrhythmias in acute myocardial infarction (author's transl)].
    Gülker H; Bender F; Thale J; Heuer H; Kristek J; Dorsel T; Pierchalla P
    Z Kardiol; 1980 Nov; 69(11):751-6. PubMed ID: 7467658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelets and antiplatelet therapy in ischemic heart disease.
    Frishman WH; Miller KP
    Curr Probl Cardiol; 1986 Feb; 11(2):69-136. PubMed ID: 2936576
    [No Abstract]   [Full Text] [Related]  

  • 9. [Detection of patients at risk for sudden heart death by long-term ECG. The role of life-threatening ventricular arrhythmias].
    Hombach V; Höpp HW; Osterspey A; Winter U; Deutsch H; Hilger HH
    Herz; 1984 Feb; 9(1):6-25. PubMed ID: 6200415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sulfinpyrazone (Anturane)--new indication: myocardial infarct?].
    Bolte HD
    MMW Munch Med Wochenschr; 1980 Apr; 122(14):507-8. PubMed ID: 6769029
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostacyclin and protection of the ischemic myocardium.
    Jouve R; Puddu PE
    Cardiologia; 1988 Apr; 33(4):339-41. PubMed ID: 3044585
    [No Abstract]   [Full Text] [Related]  

  • 12. Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.
    Polli EE; Cortellaro M
    Haematologica; 1980 Jun; 65(3):361-9. PubMed ID: 6778788
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prevention of sudden death in ischemic heart disease].
    Tsolov Ts
    Vutr Boles; 1980; 19(6):14-21. PubMed ID: 6111160
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of inhibition of platelet function with carbenicillin or aspirin on experimental canine sudden death.
    Johnson GJ; Heckel R; Leis LA; Franciosa J
    J Lab Clin Med; 1981 Nov; 98(5):660-72. PubMed ID: 7299238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Platelets and coronary artery disease (CAD) (author's transl)].
    Reimers HJ; Misera R; Schneider W; Loogen F
    Z Kardiol; 1980 Dec; 69(12):799-814. PubMed ID: 7025482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Low-dose aspirin in the long-term treatment of the patient with ischemic heart disease].
    Magnani B; Semprini F
    Cardiologia; 1994 Dec; 39(12 Suppl 1):15-21. PubMed ID: 7634259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Perspectives of the preventive treatment of patients after myocardial infarction].
    Chodorowski Z
    Pol Tyg Lek; 1984 Jan; 39(5):159-61. PubMed ID: 6146127
    [No Abstract]   [Full Text] [Related]  

  • 18. [Platelet antiaggregants in post-myocardial infarct patients: why, which and in what doses?].
    Mannucci PM
    G Ital Cardiol; 1983 Nov; 13(11):335-9. PubMed ID: 6667821
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs].
    Noll G; Kaufmann U; Wenzel RR; Lüscher TF
    Schweiz Med Wochenschr; 1996 Feb; 126(5):164-76. PubMed ID: 8685687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostacyclin offers protection against early extension of acute myocardial infarction.
    Henriksson P; Edhag O; Wennmalm A
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():435-6. PubMed ID: 2959092
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.